MYOM2 and COVID-19: Our investigation extends the understanding of strategies employed by SARS-CoV-2 to evade antiviral immunity and provides novel mechanistic insight into the mechanisms by which coronavirus M proteins inhibit IFN production, thus shedding light on the interactions between human antiviral immunity and SARS-CoV-2 infection in the pathogenesis of COVID-19.